182 related articles for article (PubMed ID: 35681673)
1. Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?
Crocco M; Verrico A; Milanaccio C; Piccolo G; De Marco P; Gaggero G; Iurilli V; Di Profio S; Malerba F; Panciroli M; Giordano P; Calevo MG; Casalini E; Di Iorgi N; Garrè ML
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681673
[TBL] [Abstract][Full Text] [Related]
2.
Del Bufalo F; Ceglie G; Cacchione A; Alessi I; Colafati GS; Carai A; Diomedi-Camassei F; De Billy E; Agolini E; Mastronuzzi A; Locatelli F
Front Oncol; 2018; 8():526. PubMed ID: 30488019
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.
Bevilacqua M; Guazzini B; Righini V; Barrella M; Toscano R; Chebat E
Curr Ther Res Clin Exp; 2004 Jul; 65(4):330-44. PubMed ID: 24672088
[TBL] [Abstract][Full Text] [Related]
4. Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children.
Guardamagna O; Amaretti A; Puddu PE; Raimondi S; Abello F; Cagliero P; Rossi M
Nutrition; 2014; 30(7-8):831-6. PubMed ID: 24985000
[TBL] [Abstract][Full Text] [Related]
5. Universal screening program for lipid disorders in 2-10 years old Lebanese children: A new approach.
Georges N; Simon A; Naim B; Georges N; Georges AF; Tanios A
Int J Pediatr Adolesc Med; 2019 Sep; 6(3):101-108. PubMed ID: 31700968
[TBL] [Abstract][Full Text] [Related]
6. Lipid profile and dyslipidemia among school-age children in urban Ghana.
Lartey A; Marquis GS; Aryeetey R; Nti H
BMC Public Health; 2018 Mar; 18(1):320. PubMed ID: 29510714
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia in Pediatric Type 2 Diabetes Mellitus.
Sunil B; Ashraf AP
Curr Diab Rep; 2020 Sep; 20(10):53. PubMed ID: 32909078
[TBL] [Abstract][Full Text] [Related]
9. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
[TBL] [Abstract][Full Text] [Related]
10. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
Wilson PWF; Jacobson TA; Martin SS; Jackson EJ; Le NA; Davidson MH; Vesper HW; Frikke-Schmidt R; Ballantyne CM; Remaley AT
J Clin Lipidol; 2021; 15(5):629-648. PubMed ID: 34802986
[TBL] [Abstract][Full Text] [Related]
11. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Morrison CC; Dunn J; Nguyen M; Blasi PR; Whitlock EP
JAMA; 2016 Aug; 316(6):634-44. PubMed ID: 27532918
[TBL] [Abstract][Full Text] [Related]
12. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
[TBL] [Abstract][Full Text] [Related]
13. Associations of thiocyanate, nitrate, and perchlorate exposure with dyslipidemia: a cross-sectional, population-based analysis.
Shi M; Zhu X; Cheang I; Zhu Q; Guo Q; Liao S; Gao R; Li X
Environ Sci Pollut Res Int; 2023 Feb; 30(7):17214-17225. PubMed ID: 36194328
[TBL] [Abstract][Full Text] [Related]
14. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
15. Targeting dyslipidemia by herbal medicines: A systematic review of meta-analyses.
Adel Mehraban MS; Tabatabaei-Malazy O; Rahimi R; Daniali M; Khashayar P; Larijani B
J Ethnopharmacol; 2021 Nov; 280():114407. PubMed ID: 34252530
[TBL] [Abstract][Full Text] [Related]
16. A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study.
Gómez-Gerique JA; Alvarez-Sala LA; Armada B; Fernández-Arias I; Martinez J; Hernández G;
Curr Ther Res Clin Exp; 2003 Jun; 64(6):338-54. PubMed ID: 24944383
[TBL] [Abstract][Full Text] [Related]
17. BRAF Inhibition in
Kaley T; Touat M; Subbiah V; Hollebecque A; Rodon J; Lockhart AC; Keedy V; Bielle F; Hofheinz RD; Joly F; Blay JY; Chau I; Puzanov I; Raje NS; Wolf J; DeAngelis LM; Makrutzki M; Riehl T; Pitcher B; Baselga J; Hyman DM
J Clin Oncol; 2018 Dec; 36(35):3477-3484. PubMed ID: 30351999
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
